Literature DB >> 6029151

Potentiation of anticoagulants.

B I Hoffbrand, D A Kininmonth.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 6029151      PMCID: PMC1843101          DOI: 10.1136/bmj.2.5555.838-b

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  [Vascular allergid due to butalidon and hazards of its combined used with athrombon (phenylindandione)].

Authors:  A KINDERMANN
Journal:  Dermatol Wochenschr       Date:  1961-02-18

2.  [Increase of anticoagulant activity with butazolidin].

Authors:  A CLAUSS; F KOLLER; H PESTALOZZI; A SIGG
Journal:  Schweiz Med Wochenschr       Date:  1956-10-20

3.  Potentiation of anticoagulant therapy by oxyphenylbutazone. (A probable case).

Authors:  C B Hobbs; A L Miller; J H Thornley
Journal:  Postgrad Med J       Date:  1965-09       Impact factor: 2.401

4.  Potentiation of anticoagulant effect of warfarin by phenylbutazone.

Authors:  P M Aggeler; R A O'Reilly; L Leong; P E Kowitz
Journal:  N Engl J Med       Date:  1967-03-02       Impact factor: 91.245

  4 in total
  7 in total

1.  Drug interactions.

Authors:  C A Winter
Journal:  Calif Med       Date:  1969-02

2.  [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors:  H Kurz
Journal:  Klin Wochenschr       Date:  1978-12-15

3.  Adverse interaction between warfarin and indomethacin.

Authors:  R Day; D Quinn
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

4.  Combining NSAIDs with anticoagulants: yes and no.

Authors:  J W O'Callaghan; R N Thompson; A S Russell
Journal:  Can Med Assoc J       Date:  1984-10-15       Impact factor: 8.262

5.  Plasma protein binding of dipyrone metabolites in man.

Authors:  E Zylber-Katz; L Granit; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 6.  The clinician's approach to drug interactions.

Authors:  H F Morrelli; K L Melmon
Journal:  Calif Med       Date:  1968-11

7.  Adverse interaction between warfarin and indomethacin.

Authors:  T Y Chan; S F Lui; S Y Chung; S Luk; J A Critchley
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.